Recalcitrant viral warts: results of treatment with the KTP laser

Gooptu, C.; James, M.P.

doi:10.1046/j.1365-2230.1999.00418.x

Cited by 23 publications

(16 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…per day) was more effective at clearing warts than low-dose cimetidine (20-30 mg kg À1 per day), 142 and 87% of children who received cimetidine for 3 months had complete resolution of their warts. 143 However, these results…”

Section: 24c Intralesional Immunotherapy (Level Of Evidence 1àmentioning

confidence: 76%

British Association of Dermatologists' guidelines for the management of cutaneous warts 2014

et al. 2014

View full text Add to dashboard Cite

Section: 24c Intralesional Immunotherapy (Level Of Evidence 1àmentioning

confidence: 76%

British Association of Dermatologists' guidelines for the management of cutaneous warts 2014

et al. 2014

View full text Add to dashboard Cite

“…137,147 Potassium-Titanyl-Phosphate (KTP) Laser The KTP laser has been utilized in the treatment of recalcitrant cutaneous warts and when treated to complete clearance, no recurrence occurred. 148 …”

Section: Neodymium:yag (Nd:yag) Lasermentioning

confidence: 99%

An Armamentarium of Wart Treatments

Lipke¹

2006

Clinical Medicine & Research

282

295

View full text Add to dashboard Cite

Patients and clinicians experience the frustration of cutaneous viral warts caused by infection with the human papilloma virus (HPV).Warts appear in various forms on different sites of the body and include common warts (verruca vulgaris), plane or flat warts, myrmecia, plantar warts, coalesced mosaic warts, filiform warts, periungual warts, anogenital warts (venereal or condyloma acuminata), oral warts and respiratory papillomas. Cervical infection with HPV is now known to cause cervical cancer if untreated. A review of the medical literature reveals a huge armamentarium of wart monotherapies and combination therapies. Official evidence-based guidelines exist for the treatment of warts, but very few of the reported treatments have been tested by rigorous blinded, randomized controlled trials.Therefore, official recommendations do not often include treatments with reportedly high success rates, but they should not be ignored when considering treatment options. It is the purpose of this review to provide a comprehensive overview of the wart treatment literature to expand awareness of the options available to practitioners faced with patients presenting with problematic warts. Warts of the genital tract carry a much more ominous and pernicious threat for women in particular. It has been estimated that up to 70% of sexually active women become infected during their lifetime with human papillomavirus (HPV), the infective agent that causes warts. 3-5 A causal role for HPV infections in cervical cancer has been documented beyond reasonable doubt. HPV DNA is present in virtually all cervical cancer cases worldwide, with it being detected in 99.7% of an international series of cervical cancers by genetic amplification techniques and in 100% of cases as confirmed by histological review. 6,7 Cervical cancer is the most frequent common cancer in developing countries and the second most common cancer in women worldwide. 3 The association between HPV infection and cervical cancer is so strong that HPV is now considered the first positive cause of any human cancer ever identified. 3This raises the level of concerns over HPV prevention, screening and treatment from that of a nuisance condition to that of a major public health concern. Attention is beginning to focus on the viral factors that determine persistence and neoplastic progression to cancer and the possible role of HPV in other nongenital cancers (e.g., skin, upper aerodigestive tract). [8][9][10][11][12][13][14][15][16][17] Patients with warts seek advice from general practitioners, pharmacists, naturopaths, allied health professionals, family or friends, dermatologists, gynecologists, obstetricians and pediatricians for treatment and may present with recalcitrant warts that have been previously treated with anything from folk remedies to hypnosis to over-the-counter medications to more aggressive clinic-based treatments. Unfortunately, even with years of medical literature on this subject, high-quality, level I evidence for the efficacy of almost all treatments is no...

show abstract

“…Gooptu und James erreichten 1999 mit einem 532 nm KTP-Neodym-YAG-Laser (grünes Licht) bei 25 Patienten nach durchschnittlich 3 Behandlungen in 50% totale Abheilung der Warzen [4]. Wimmershoff et al zeigten 2001 mit einem 595 nm LPTDL ("long pulse tunable dye laser") an 24 Patienten eine Heilungsrate von lediglich 6,5%, allerdings an einem negativ selektionierten Patientengut, das zu mehr als 60% aus Immunsupprimierten und Atopikern bestand [17].…”

Section: Materials Und Methoden Farbstofflaserunclassified

Verrucae vulgares Behandlung mit dem Farbstofflaser

Kopera

2002

Hautarzt

View full text Add to dashboard Cite

show abstract

Recalcitrant viral warts: results of treatment with the KTP laser

Cited by 23 publications

References 4 publications

British Association of Dermatologists' guidelines for the management of cutaneous warts 2014

British Association of Dermatologists' guidelines for the management of cutaneous warts 2014

An Armamentarium of Wart Treatments

Verrucae vulgares Behandlung mit dem Farbstofflaser

Contact Info

Product

Resources

About